Literature DB >> 15537356

Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.

Wioleta Kowalczyk1, Adam Prahl, Izabela Derdowska, Olga Dawidowska, Jirina Slaninová, Bernard Lammek.   

Abstract

The synthesis and some pharmacological properties of two sets of analogues, one consisting of six peptides with 1-aminocyclohexane-1-carboxylic acid (Acc) in position 2 and the other with the amino acid in position 3, have been described. All the peptides were tested for their pressor, antidiuretic, and uterotonic in vitro activities. The Acc(2) modification has been shown to selectively modulate the activities of the analogues. Four of the compounds were highly potent antidiuretic agonists with different pressor and uterotonic activities. On the other hand, the 3-substituted counterparts failed to exhibit any of the activities. One exception was provided by the [Mpa(1),Acc(3),Val(4),D-Arg(8)]VP analogue, which exhibited antidiuretic activity matching that of AVP, yet, unlike AVP, it was fairly selective.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537356     DOI: 10.1021/jm040813o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Side-chain to backbone interactions dictate the conformational preferences of a cyclopentane arginine analogue.

Authors:  Guillem Revilla-López; Juan Torras; Ana I Jiménez; Carlos Cativiela; Ruth Nussinov; Carlos Alemán
Journal:  J Org Chem       Date:  2009-03-20       Impact factor: 4.354

2.  Application of 1-aminocyclohexane carboxylic acid to protein nanostructure computer design.

Authors:  Francisco Rodríguez-Ropero; David Zanuy; Jordi Casanovas; Ruth Nussinov; Carlos Alemán
Journal:  J Chem Inf Model       Date:  2008-01-17       Impact factor: 4.956

Review 3.  Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.

Authors:  Mladena Glavaš; Agata Gitlin-Domagalska; Dawid Dębowski; Natalia Ptaszyńska; Anna Łęgowska; Krzysztof Rolka
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.